158 related articles for article (PubMed ID: 25052350)
1. Prognostic stratification of brain metastases from hepatocellular carcinoma.
Kim KS; Kim K; Chie EK; Kim YJ; Yoon JH; Lee HS; Ha SW
J Neurooncol; 2014 Oct; 120(1):209-14. PubMed ID: 25052350
[TBL] [Abstract][Full Text] [Related]
2. Nomogram prediction of survival in patients with brain metastases from hepatocellular carcinoma treated with whole-brain radiotherapy: a multicenter retrospective study.
Park Y; Kim KS; Kim K; Chie EK; Kim JH; Kim JS; Kim TH; Kim DY; Jang WI; Kim MS; Koo TR; Chang AR
J Neurooncol; 2015 Nov; 125(2):377-83. PubMed ID: 26342711
[TBL] [Abstract][Full Text] [Related]
3. Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC.
Choi HJ; Cho BC; Sohn JH; Shin SJ; Kim SH; Kim JH; Yoo NC
J Neurooncol; 2009 Feb; 91(3):307-13. PubMed ID: 18949445
[TBL] [Abstract][Full Text] [Related]
4. Gamma Knife surgery for treating brain metastases arising from hepatocellular carcinomas.
Park ES; Kwon DH; Park JB; Lee DH; Cho YH; Kim JH; Kim CJ
J Neurosurg; 2014 Dec; 121 Suppl():102-9. PubMed ID: 25434943
[TBL] [Abstract][Full Text] [Related]
5. Control of intracranial disease is associated with improved survival in patients with brain metastasis from hepatocellular carcinoma.
Nam HC; Sung PS; Song DS; Kwon JH; Nam SW; Yoon DJ; Jang JW; Choi JY; Yoon SK; Moon SW; Jang HS; Park JS; Jeun SS; Hong YK; Bae SH
Int J Clin Oncol; 2019 Jun; 24(6):666-676. PubMed ID: 30788672
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma specific graded prognostic assessment can predict outcomes for patients with brain metastases from hepatocellular carcinoma.
Lim S; Lee S; Lim JY; Park JS; Seong JS; Chang WS; Han KH; Choi HJ
J Neurooncol; 2014 Oct; 120(1):199-207. PubMed ID: 25062667
[TBL] [Abstract][Full Text] [Related]
7. Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors.
Jiang XB; Ke C; Zhang GH; Zhang XH; Sai K; Chen ZP; Mou YG
BMC Cancer; 2012 Feb; 12():49. PubMed ID: 22292912
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors and grading systems for overall survival in patients treated with radiosurgery for brain metastases: variation by primary site.
Golden DW; Lamborn KR; McDermott MW; Kunwar S; Wara WM; Nakamura JL; Sneed PK
J Neurosurg; 2008 Dec; 109 Suppl():77-86. PubMed ID: 19123892
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of stereotactic radiosurgery with and without whole-brain radiotherapy for the treatment of newly diagnosed brain metastases.
Hall MD; McGee JL; McGee MC; Hall KA; Neils DM; Klopfenstein JD; Elwood PW
J Neurosurg; 2014 Dec; 121 Suppl():84-90. PubMed ID: 25434941
[TBL] [Abstract][Full Text] [Related]
10. Clinical outcomes of brain metastases from hepatocellular carcinoma: a multicenter retrospective study and a literature review.
Okuda T; Hayashi N; Takahashi M; Uzuka T; Okita Y; Otani R; Fujinaka T; Fujita M; Kato A; Narita Y; Nakasu Y
Int J Clin Oncol; 2018 Dec; 23(6):1095-1100. PubMed ID: 29968168
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular carcinoma with extrahepatic metastasis: clinical features and prognostic factors.
Uchino K; Tateishi R; Shiina S; Kanda M; Masuzaki R; Kondo Y; Goto T; Omata M; Yoshida H; Koike K
Cancer; 2011 Oct; 117(19):4475-83. PubMed ID: 21437884
[TBL] [Abstract][Full Text] [Related]
12. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; GuimarĂ£es FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
13. Local tumor response and survival outcomes after combined stereotactic radiosurgery and immunotherapy in non-small cell lung cancer with brain metastases.
Singh C; Qian JM; Yu JB; Chiang VL
J Neurosurg; 2019 Feb; 132(2):512-517. PubMed ID: 30771783
[TBL] [Abstract][Full Text] [Related]
14. [Brain metastases from hepatocellular carcinoma: clinical features and prognostic factors in 31 cases].
Zhang RL; Zhang H; Zhang L; Xiao L; Sun YN; Yang Y; Bao YX
Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):305-9. PubMed ID: 27087379
[TBL] [Abstract][Full Text] [Related]
15. Application of recursive partitioning analysis and evaluation of the use of whole brain radiation among patients treated with stereotactic radiosurgery for newly diagnosed brain metastases.
Chidel MA; Suh JH; Reddy CA; Chao ST; Lundbeck MF; Barnett GH
Int J Radiat Oncol Biol Phys; 2000 Jul; 47(4):993-9. PubMed ID: 10863070
[TBL] [Abstract][Full Text] [Related]
16. Brain Metastases from Ovarian Carcinoma: An Evaluation of Prognostic Factors and Treatment.
Wohl A; Kimchi G; Korach J; Perri T; Zach L; Zibly Z; Harel R; Nissim U; Spiegelmann R; Nass D; Cohen ZR
Neurol India; 2019; 67(6):1431-1436. PubMed ID: 31857529
[TBL] [Abstract][Full Text] [Related]
17. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.
Andrews DW; Scott CB; Sperduto PW; Flanders AE; Gaspar LE; Schell MC; Werner-Wasik M; Demas W; Ryu J; Bahary JP; Souhami L; Rotman M; Mehta MP; Curran WJ
Lancet; 2004 May; 363(9422):1665-72. PubMed ID: 15158627
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy for brain metastases from renal cell cancer: should whole-brain radiotherapy be added to stereotactic radiosurgery?: analysis of 88 patients.
Fokas E; Henzel M; Hamm K; Surber G; Kleinert G; Engenhart-Cabillic R
Strahlenther Onkol; 2010 Apr; 186(4):210-7. PubMed ID: 20165820
[TBL] [Abstract][Full Text] [Related]
19. Comparison of stereotactic radiosurgery (SRS) alone and whole brain radiotherapy (WBRT) plus a stereotactic boost (WBRT+SRS) for one to three brain metastases.
Rades D; Kueter JD; Hornung D; Veninga T; Hanssens P; Schild SE; Dunst J
Strahlenther Onkol; 2008 Dec; 184(12):655-62. PubMed ID: 19107346
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic radiosurgery using the Leksell Gamma Knife Perfexion unit in the management of patients with 10 or more brain metastases.
Grandhi R; Kondziolka D; Panczykowski D; Monaco EA; Kano H; Niranjan A; Flickinger JC; Lunsford LD
J Neurosurg; 2012 Aug; 117(2):237-45. PubMed ID: 22631694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]